Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.6 - $1.53 $33 - $85
-56 Reduced 0.06%
99,813 $59,000
Q2 2023

Aug 14, 2023

SELL
$1.05 - $1.63 $536,727 - $833,205
-511,169 Reduced 83.66%
99,869 $112,000
Q1 2023

May 15, 2023

SELL
$1.2 - $2.73 $1.08 Million - $2.46 Million
-901,253 Reduced 59.6%
611,038 $824,000
Q4 2022

Feb 14, 2023

SELL
$1.71 - $3.61 $922,678 - $1.95 Million
-539,578 Reduced 26.3%
1,512,291 $2.81 Million
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $958,540 - $4.35 Million
-504,495 Reduced 19.73%
2,051,869 $5.05 Million
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $1.84 Million - $7.78 Million
-863,102 Reduced 25.24%
2,556,364 $6.24 Million
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $2.39 Million - $5.93 Million
-380,453 Reduced 10.01%
3,419,466 $27.3 Million
Q4 2021

Feb 14, 2022

SELL
$14.7 - $28.67 $43.3 Million - $84.4 Million
-2,943,357 Reduced 43.65%
3,799,919 $58 Million
Q3 2021

Nov 15, 2021

SELL
$24.31 - $33.6 $1.05 Million - $1.45 Million
-43,273 Reduced 0.64%
6,743,276 $192 Million
Q2 2021

Aug 16, 2021

SELL
$26.09 - $40.4 $4.99 Million - $7.72 Million
-191,142 Reduced 2.74%
6,786,549 $229 Million
Q1 2021

May 17, 2021

SELL
$33.06 - $56.93 $1.2 Million - $2.07 Million
-36,302 Reduced 0.52%
6,977,691 $267 Million
Q4 2020

Feb 16, 2021

SELL
$39.09 - $57.4 $3.03 Million - $4.44 Million
-77,393 Reduced 1.09%
7,013,993 $293 Million
Q3 2020

Nov 16, 2020

SELL
$28.43 - $44.67 $5.63 Million - $8.84 Million
-197,974 Reduced 2.72%
7,091,386 $307 Million
Q2 2020

Aug 14, 2020

BUY
$11.71 - $30.29 $11.5 Million - $29.7 Million
979,097 Added 15.52%
7,289,360 $221 Million
Q1 2020

May 15, 2020

BUY
$7.64 - $27.5 $11.4 Million - $40.9 Million
1,488,286 Added 30.86%
6,310,263 $86.3 Million
Q4 2019

Feb 14, 2020

SELL
$15.02 - $20.57 $1.65 Million - $2.26 Million
-109,939 Reduced 2.23%
4,821,977 $77.8 Million
Q3 2019

Nov 14, 2019

SELL
$18.85 - $27.5 $5.31 Million - $7.74 Million
-281,550 Reduced 5.4%
4,931,916 $95 Million
Q2 2019

Aug 13, 2019

SELL
$17.37 - $26.27 $5.5 Million - $8.32 Million
-316,571 Reduced 5.72%
5,213,466 $123 Million
Q1 2019

May 17, 2019

BUY
$10.65 - $25.75 $6.09 Million - $14.7 Million
572,234 Added 11.54%
5,530,037 $130 Million
Q4 2018

Feb 14, 2019

BUY
$9.26 - $16.38 $7.81 Million - $13.8 Million
842,977 Added 20.49%
4,957,803 $54.8 Million
Q3 2018

Oct 30, 2018

BUY
$7.54 - $18.31 $31 Million - $75.3 Million
4,114,826 New
4,114,826 $68.8 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.